Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?

Published:2018-06 Issue: Volume:131 Page:122-131
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Mühlebach Stefan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference35 articles.

1. Development considerations for nanocrystal drug products;Chen;AAPS J.,2017

2. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similar;Mühlebach;Nanomedicine,2015

3. Equivalence of complex drug products: advances in and challenges for current regulatory pathways;Hussaarts;Ann. N. Y. Acad. Sci.,2017

4. Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?;Knoeff;Eur. J. Hosp. Pharm.,2018

5. How to select a nanosimilar;Astier;Ann. N. Y. Acad. Sci.,2017

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissimilar ferric derisomaltose formulations – In vitro comparisons between an originator and its intended similars;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices;Drug Delivery and Translational Research;2024-08-10

3. Computational Approaches for Drug Delivery of Nanoparticles;Drug Delivery Systems Using Quantum Computing;2024-07

4. Chitosan-based nanomedicines: A review of the main challenges for translating the science of polyelectrolyte complexation into innovative pharmaceutical products;Carbohydrate Polymer Technologies and Applications;2024-06

5. Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials;Nano Today;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3